Benefit–Risk or Risk–Benefit Trade-Offs? Another Look at Attribute Ordering Effects in a Pilot Choice Experiment

被引：0
|
作者：
Sebastian Heidenreich
Andrea Phillips-Beyer
Bruno Flamion
Melissa Ross
Jaein Seo
Kevin Marsh
机构：
[1] Evidera Inc.,
[2] Innovus Consulting,undefined
[3] Idorsia Pharmaceuticals Ltd,undefined
来源：
The Patient - Patient-Centered Outcomes Research | 2021年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：65 / 74
页数：9
相关论文
共 50 条
  • [41] Method for Calculating the Simultaneous Maximum Acceptable Risk Threshold (SMART) from Discrete-Choice Experiment Benefit-Risk Studies
    Fairchild, Angelyn Otteson
    Reed, Shelby D.
    Gonzalez, Juan Marcos
    MEDICAL DECISION MAKING, 2023, 43 (02) : 227 - 238
  • [42] Effects of multiple vertebrate predators on grasshopper habitat selection: trade-offs due to predation risk, foraging, and thermoregulation
    Pitt, WC
    EVOLUTIONARY ECOLOGY, 1999, 13 (05) : 499 - 515
  • [43] Effects of multiple vertebrate predators on grasshopper habitat selection: trade-offs due to predation risk, foraging, and thermoregulation
    William C. Pitt
    Evolutionary Ecology, 1999, 13 : 499 - 516
  • [44] A discrete choice experiment evaluation of patients' preferences for different risk, benefit, and delivery attributes of insulin therapy for diabetes management
    Guimaraes, Camila
    Marra, Carlo A.
    Gill, Sabrina
    Simpson, Scot
    Meneilly, Graydon
    Queiroz, Regina H. C.
    Lynd, Larry D.
    PATIENT PREFERENCE AND ADHERENCE, 2010, 4 : 433 - 440
  • [45] Discrete Choice Experiment (DCE) as A Tool to Elicit Patient Preferences in A Complex Benefit-Risk Evaluation: A Rimonabant Case Study
    Jian-Yu, E.
    Shahrul, Mt-Isa
    Hockley, Kimberley
    Juhaeri, Juhaeri
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 524 - 524
  • [46] A benefit-risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients
    Byun, Ji-Hye
    Kwon, Sun-Hong
    Ha, Ji-Hye
    Lee, Eui-Kyung
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 965 - 974
  • [47] Communicating on Vaccine Benefit-Risk Ratios: A Discrete-Choice Experiment among Health Care Professionals and the General Population in France
    Chaveron, Lucia Araujo
    Sicsic, Jonathan
    Olivier, Cyril
    Pellissier, Gerard
    Bouvet, Elisabeth
    Mueller, Judith E.
    MEDICAL DECISION MAKING, 2025, 45 (02) : 177 - 191
  • [48] A study to evaluate patient benefit/risk preferences for treatment of metastatic prostate cancer (mPC) in Hong Kong: A discrete choice experiment.
    Ng, Chi-Fai
    Hong, Yeuk-Lam
    Wong, Kenneth C. W.
    Kong, Wing-Yan
    Leung, Chi-ho
    Lai, Pui-Tak
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [49] Patient-Focused Drug Development Methods for Benefit-Risk Assessments: A Case Study Using a Discrete Choice Experiment for Antiepileptic Drugs
    Holmes, Emily A. F.
    Plumpton, Catrin
    Baker, Gus A.
    Jacoby, Ann
    Ring, Adele
    Williamson, Paula
    Marson, Anthony
    Hughes, Dyfrig A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (03) : 672 - 683
  • [50] Trade-offs between overall survival and side effects in the treatment of metastatic breast cancer: eliciting preferences of patients with primary and metastatic breast cancer using a discrete choice experiment
    Bullen, Alistair
    Ryan, Mandy
    Ennis, Holly
    Gray, Ewan
    Loria-Rebolledo, Luis Enrique
    Mcintyre, Morag
    Hall, Peter
    BMJ OPEN, 2024, 14 (04):
12345